QIM26-286: Ambulatory Blinatumomab via Infusion Pump: A FMEA-Driven Quality Improvement to Reduce Bed Utilization and Elevate Patient/Staff Experience and Decrease Cost
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Healthcare Quality and Management
Intravenous Infusion Technology and Safety
Acute Lymphoblastic Leukemia research
Publication details
- Journal / source
- Journal of the National Comprehensive Cancer Network
- Volume
- 24
- Issue
- 3.5
- Publication date
- 27 March 2026
- Language
- EN